Monday, December 4, 2006

NBI Development Gets $5.5M

San Francisco-based NBI Development, a medical devices company, said today that it has raised $5.5M in a first round of funding. NBI said that the seed round was co-led by Three Arch Partners and Bay City Capital, and also included MPM Capital, Aberdare Ventures, Mayo Clinic, and the Venturi Group. NBI was co-founded by the Mayo Clinical, Bay City Capital, and the Venturi Group to focus on chronic pain management products. The firm is developing medical products around neuromodulation. More information »